Singapore markets open in 4 hours 1 minute

Kiniksa Pharmaceuticals, Ltd. (KNSA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
20.19-0.07 (-0.35%)
At close: 04:00PM EDT
20.19 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
107,954
122,715
122,470
114,038
Other short-term investments
98,417
67,893
59,731
209,444
Total cash
206,371
190,608
182,201
323,482
Net receivables
21,266
12,660
3,985
0
Inventory
31,122
21,599
3,675
0
Other current assets
17,538
10,537
6,585
9,557
Total current assets
276,297
243,060
196,446
333,249
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
20,450
13,902
14,299
15,347
Accumulated depreciation
-7,785
-6,859
-5,915
-4,730
Net property, plant and equipment
12,665
7,043
8,384
10,617
Intangible assets
17,250
18,250
19,250
-
Other long-term assets
827
5,824
8,720
5,588
Total non-current assets
250,025
216,612
36,354
16,215
Total assets
526,322
459,672
232,800
349,464
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
8,246
7,899
1,868
503
Accrued liabilities
28,713
18,899
29,115
21,495
Deferred revenues
307
0
-
-
Other current liabilities
8,193
5,754
1,544
37
Total current liabilities
63,666
47,066
44,824
31,846
Non-current liabilities
Deferred revenues
11,954
12,000
0
-
Other long-term liabilities
1,858
1,839
270
805
Total non-current liabilities
23,817
16,457
2,939
5,683
Total liabilities
87,483
63,523
47,763
37,529
Stockholders' equity
Common stock
20
19
18
18
Retained earnings
-477,950
-492,034
-675,397
-517,473
Accumulated other comprehensive income
6
44
-66
-34
Total stockholders' equity
438,839
396,149
185,037
311,935
Total liabilities and stockholders' equity
526,322
459,672
232,800
349,464